-
1
-
-
0022879288
-
Antidepressant biochemical profile of the novel bicyclic compound, Wy-45,030, an ethyl cyclohexanol derivative
-
Muth FA, Haskins JT, Moyer JA, Husbands GEM, Nielsen ST, Sigg SB. Antidepressant biochemical profile of the novel bicyclic compound, Wy-45,030, an ethyl cyclohexanol derivative. Biochem Pharmacol 1986;35:4493-7.
-
(1986)
Biochem Pharmacol
, vol.35
, pp. 4493-4497
-
-
Muth, F.A.1
Haskins, J.T.2
Moyer, J.A.3
Husbands, G.E.M.4
Nielsen, S.T.5
Sigg, S.B.6
-
3
-
-
0025834267
-
Placebo-controlled trial of venlafaxine for the treatment of major depression
-
Schweizer E, Weise L, Clary C, Fox I, Richels K. Placebo-controlled trial of venlafaxine for the treatment of major depression. J Clin Psychopharmacol 1991;11:233-6.
-
(1991)
J Clin Psychopharmacol
, vol.11
, pp. 233-236
-
-
Schweizer, E.1
Weise, L.2
Clary, C.3
Fox, I.4
Richels, K.5
-
4
-
-
0027485783
-
Efficacy and safety of b.i.d. doses of venlafaxine in a dose-response study
-
Mendels J, Johnson R, Mattes J, Riesenberg R. Efficacy and safety of b.i.d. doses of venlafaxine in a dose-response study. Psychopharmacol Bull 1993;29:169-74.
-
(1993)
Psychopharmacol Bull
, vol.29
, pp. 169-174
-
-
Mendels, J.1
Johnson, R.2
Mattes, J.3
Riesenberg, R.4
-
5
-
-
0028073950
-
Long-term safety and clinical acceptability of venlafaxine and imipramine in outpatients with major depression
-
Shrivastava RK, Cohn C, Crowder J, Davidson J, Dunner D, Feighner J, Kiev A, Patrick R. Long-term safety and clinical acceptability of venlafaxine and imipramine in outpatients with major depression. J Clin Psychopharmacol 1994;14:322-9.
-
(1994)
J Clin Psychopharmacol
, vol.14
, pp. 322-329
-
-
Shrivastava, R.K.1
Cohn, C.2
Crowder, J.3
Davidson, J.4
Dunner, D.5
Feighner, J.6
Kiev, A.7
Patrick, R.8
-
6
-
-
0021270108
-
Antidepressant withdrawal phenomena
-
Dilsaver S, Greden J. Antidepressant withdrawal phenomena. Biol Psychiatry 1984;19:237-50.
-
(1984)
Biol Psychiatry
, vol.19
, pp. 237-250
-
-
Dilsaver, S.1
Greden, J.2
-
8
-
-
0023499777
-
Can antidepressants cause mania and worsen the course of affective illness?
-
Wehr TA, Goodwin FK. Can antidepressants cause mania and worsen the course of affective illness? Am J Psychiatry 1987;144:1403-11.
-
(1987)
Am J Psychiatry
, vol.144
, pp. 1403-1411
-
-
Wehr, T.A.1
Goodwin, F.K.2
-
10
-
-
0025869797
-
The serotonin syndrome
-
Sternbach H. The serotonin syndrome. Am J Psychiatry 1991;148:705-13.
-
(1991)
Am J Psychiatry
, vol.148
, pp. 705-713
-
-
Sternbach, H.1
-
11
-
-
27844595432
-
Prescribing information: Effexor® (venlafaxine hydrochloride)
-
Montvale, NJ: Medical Economics Data Production Company
-
Prescribing information: Effexor® (venlafaxine hydrochloride). Physicians' Desk Reference®. Montvale, NJ: Medical Economics Data Production Company, 1995:2664-8.
-
(1995)
Physicians' Desk Reference®
, pp. 2664-2668
-
-
-
12
-
-
0025878208
-
Biochemical, neurophysiological, and behavioral effects of WY-45,233 and other identified metabolites of the antidepressant venlafaxine
-
Muth EA, Moyer JA, Haskins JT, Andree TH, Husbands GEM. Biochemical, neurophysiological, and behavioral effects of WY-45,233 and other identified metabolites of the antidepressant venlafaxine. Drug Dev Res 1991;23:191-9.
-
(1991)
Drug Dev Res
, vol.23
, pp. 191-199
-
-
Muth, E.A.1
Moyer, J.A.2
Haskins, J.T.3
Andree, T.H.4
Husbands, G.E.M.5
-
13
-
-
0029562267
-
Cardiovascular safety in depressed patients - focus on venlafaxine
-
Feighner JP. Cardiovascular safety in depressed patients - focus on venlafaxine. J Clin Psychiatry 1995;56:574-9.
-
(1995)
J Clin Psychiatry
, vol.56
, pp. 574-579
-
-
Feighner, J.P.1
|